Maxim analyst Anthony Vendetti downgraded Nexalin Technology (NXL) to Hold from Buy.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NXL:
- Nexalin Technology announces peer-reviewed publication on DIFS technology
- Nexalin Technology releases letter to shareholders
- Nexalin Technology’s Strong Financial Position: No Defaults on Senior Securities
- Nexalin Technology regains compliance with Nasdaq continued listing rules
- Nexalin announces study on AD, DIFS published in Journal of Alzheimer’s Disease